BlackRock Health Sciences Opps Inv C
- SHSCX
- Price as of: Nov 20, 2020
-
$62.56
N/A N/A
- Primary Theme
- Health Care Sector Equity
- Fund Company
- BlackRock
- Share Class
SHSCX - Snapshot
Vitals
- YTD Return 11.9%
- 3 Yr Annualized Return 12.7%
- 5 Yr Annualized Return 10.9%
- Net Assets $9.33 B
- Holdings in Top 10 35.8%
52 WEEK LOW AND HIGH
$62.56
$41.56
$64.30
Expenses
OPERATING RELATED FEES
- Expense Ratio 1.85%
SALES FEES
- Front Load N/A
- Deferred Load 1.00%
BROKERAGE FEES
- Turnover 41.00%
TRADING FEES
- Max Redemption Fee N/A
Min Investment
- Standard (Taxable) $1,000
- IRA N/A
Fund Classification
-
Primary Theme
Health Care Sector Equity
- Fund Type Open End Mutual Fund
- Investment Style Health
SHSCX - Profile
Distributions
- YTD Total Return 11.9%
- 3 Yr Annualized Total Return 12.7%
- 5 Yr Annualized Total Return 10.9%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.56%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameBlackRock Health Sciences Opportunities Portfolio
-
Fund Family NameBlackRock
-
Inception DateOct 16, 2000
-
Shares OutstandingN/A
-
Share ClassC
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerErin Xie
Fund Description
The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.
SHSCX - Performance
Return Ranking - Trailing
| Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 11.9% | -5.5% | 128.1% | 60.25% |
| 1 Yr | 14.7% | -1.4% | 132.6% | 63.75% |
| 3 Yr | 12.7%* | 0.8% | 40.7% | 34.27% |
| 5 Yr | 10.9%* | -0.7% | 29.6% | 22.86% |
| 10 Yr | 15.4%* | 8.1% | 19.7% | 51.22% |
* Annualized
Return Ranking - Calendar
| Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2019 | 19.3% | 3.8% | 63.8% | 62.76% |
| 2018 | -1.0% | -49.7% | 21.5% | 24.82% |
| 2017 | 19.1% | -59.8% | 54.4% | 48.15% |
| 2016 | -9.2% | -36.6% | 11.6% | 24.81% |
| 2015 | -3.3% | -62.4% | 27.9% | 68.03% |
Total Return Ranking - Trailing
| Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 11.9% | -5.5% | 128.1% | 60.25% |
| 1 Yr | 13.7% | -6.5% | 132.6% | 67.50% |
| 3 Yr | 12.7%* | -0.3% | 40.7% | 30.77% |
| 5 Yr | 10.9%* | -0.7% | 29.6% | 20.71% |
| 10 Yr | 15.4%* | 8.1% | 19.7% | 47.97% |
* Annualized
Total Return Ranking - Calendar
| Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2019 | 19.3% | 3.8% | 63.8% | 62.76% |
| 2018 | -1.0% | -25.3% | 22.2% | 34.31% |
| 2017 | 19.1% | -10.8% | 54.4% | 59.26% |
| 2016 | -9.2% | -36.6% | 11.6% | 36.43% |
| 2015 | -3.3% | -16.6% | 27.9% | 77.87% |
NAV & Total Return History
SHSCX - Holdings
Concentration Analysis
| SHSCX | Category Low | Category High | SHSCX % Rank | |
|---|---|---|---|---|
| Net Assets | 9.33 B | 3.74 M | 46 B | 5.81% |
| Number of Holdings | 141 | 24 | 426 | 13.37% |
| Net Assets in Top 10 | 3.47 B | 952 K | 19.6 B | 8.14% |
| Weighting of Top 10 | 35.79% | 14.0% | 75.7% | 68.02% |
Top 10 Holdings
- UnitedHealth Group Inc 6.88%
- Abbott Laboratories 5.24%
- Johnson & Johnson 4.49%
- Thermo Fisher Scientific Inc 3.35%
- Boston Scientific Corp 2.84%
- Amgen Inc 2.82%
- Medtronic PLC 2.73%
- Humana Inc 2.54%
- Edwards Lifesciences Corp 2.53%
- Seagen Inc Ordinary Shares 2.45%
Asset Allocation
| Weighting | Return Low | Return High | SHSCX % Rank | |
|---|---|---|---|---|
| Stocks | 96.69% | 61.47% | 102.50% | 77.33% |
| Cash | 2.08% | -0.01% | 32.46% | 41.28% |
| Other | 1.22% | -2.50% | 6.07% | 14.53% |
| Preferred Stocks | 0.00% | 0.00% | 6.63% | 29.07% |
| Convertible Bonds | 0.00% | 0.00% | 0.06% | 18.60% |
| Bonds | 0.00% | 0.00% | 16.11% | 20.35% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | SHSCX % Rank | |
|---|---|---|---|---|
| Healthcare | 98.89% | 61.81% | 100.00% | 70.93% |
| Basic Materials | 0.59% | 0.00% | 2.60% | 17.44% |
| Financial Services | 0.53% | 0.00% | 3.31% | 16.28% |
| Utilities | 0.00% | 0.00% | 0.00% | 17.44% |
| Technology | 0.00% | 0.00% | 15.86% | 30.23% |
| Real Estate | 0.00% | 0.00% | 6.03% | 23.26% |
| Industrials | 0.00% | 0.00% | 5.94% | 26.74% |
| Energy | 0.00% | 0.00% | 0.00% | 17.44% |
| Communication Services | 0.00% | 0.00% | 4.69% | 20.93% |
| Consumer Defense | 0.00% | 0.00% | 34.31% | 23.84% |
| Consumer Cyclical | 0.00% | 0.00% | 1.09% | 25.00% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | SHSCX % Rank | |
|---|---|---|---|---|
| US | 86.70% | 47.91% | 99.98% | 29.65% |
| Non US | 9.99% | 0.00% | 43.79% | 72.09% |
SHSCX - Expenses
Operational Fees
| SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 1.85% | 0.08% | 25.14% | 21.08% |
| Management Fee | 0.68% | 0.00% | 1.25% | 54.65% |
| 12b-1 Fee | 1.00% | 0.00% | 1.00% | 78.67% |
| Administrative Fee | N/A | 0.03% | 0.40% | 16.67% |
Sales Fees
| SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 3.50% | 5.75% | N/A |
| Deferred Load | 1.00% | 1.00% | 5.00% | 23.81% |
Trading Fees
| SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 41.00% | 0.70% | 252.00% | 60.12% |
SHSCX - Distributions
Dividend Yield Analysis
| SHSCX | Category Low | Category High | SHSCX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 3.15% | 32.56% |
Dividend Distribution Analysis
| SHSCX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Net Income Ratio Analysis
| SHSCX | Category Low | Category High | SHSCX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.56% | -2.53% | 2.53% | 82.04% |
Capital Gain Distribution Analysis
| SHSCX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
SHSCX - Fund Manager Analysis
Managers
Erin Xie
Start Date
Tenure
Tenure Rank
Jul 31, 2003
17.27
17.3%
Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.
Xiang Liu
Start Date
Tenure
Tenure Rank
Jun 01, 2020
0.42
0.4%
Jeff Lee
Start Date
Tenure
Tenure Rank
Jun 01, 2020
0.42
0.4%
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.09 | 23.14 | 7.28 | 20.52 |